Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma (Q58455748)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Gareth J Morgan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Nicholas Cross

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

F M Ross

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A H Ibrahim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Vilain-Holmes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

M O Winfield

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

L Chiecchio

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

R K M Protheroe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

P Strike

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

J L Gunasekera

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Jones

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

UK Myeloma Forum

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

1634-1642

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15990862%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403857

13 January 2020

exact match

0 references

cites work

Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Multiple myeloma: almost all patients are cytogenetically abnormal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Genetics and cytogenetics of multiple myeloma: a workshop report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Advances in biology of multiple myeloma: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Multiple myeloma: evolving genetic events and host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Clinical and biologic implications of recurrent genomic aberrations in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Diagnosis and management of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Analysis of p73 and p53 gene deletions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Hypodiploidy is a major prognostic factor in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021

Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403857

7 January 2021